Biological Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis of Polyarticular Course, Enthesitis-Related Arthritis, and Psoriatic Arthritis: A Consensus Statement

doi 10.12809/hkmj198195
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hong Kong Academy of Medicine Press

Related search

Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis

2020English

Assessing the Effectiveness of Synthetic and Biologic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis &Ndash; A Systematic Review

Psoriasis: Targets and Therapy
DermatologyRheumatology
2015English

Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2014English

Polyarticular Juvenile Idiopathic Arthritis &Ndash; Epidemiology and Management Approaches

Clinical Epidemiology
Epidemiology
2014English

Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs

Reumatologia
RheumatologyAllergyImmunology
2014English

Polyarticular Juvenile Idiopathic Arthritis (pJIA): Clinical and Serologic Predictors of Inactive Disease (ID)

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Enthesitis as a Component of Dactylitis in Psoriatic Juvenile Idiopathic Arthritis: Histology of an Established Clinical Entity

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2015English

Juvenile Idiopathic Arthritis

The Lancet
Medicine
2007English

Juvenile Idiopathic Arthritis

2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy